Extavia and Naproxen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Extavia (interferon beta-1b) and Naproxen (naproxen). Common drug interactions include injection site erythema among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Extavia and Naproxen. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Extavia?
Extavia has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 4,888 Extavia users. Check the latest studies of Extavia.
What is Naproxen?
Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,032 Naproxen users. Check the latest studies of Naproxen.
38 people who take Extavia and Naproxen together, and have interactions are studied.

What are the common drug interactions of Extavia and Naproxen, by gender? *:
female:
- Injection site erythema (redness at injection site)
- Injection site pain
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Migraine (headache)
- Injection site haematoma (localized swelling filled with blood at injection site)
- Headache (pain in head)
- Fatigue (feeling of tiredness)
- Memory impairment
- Muscular weakness (muscle weakness)
- Stress
male:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Gait disturbance
- Muscular weakness (muscle weakness)
- Hypoaesthesia (reduced sense of touch or sensation)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Urinary retention (the inability to completely or partially empty the bladder)
- Vision blurred
- Hepatic enzyme increased
- Neuropathy peripheral (surface nerve damage)
What are the common drug interactions of Extavia and Naproxen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Abdominal discomfort
- Chills (felling of cold)
- Headache (pain in head)
- Hyperhidrosis (abnormally increased sweating)
- Insomnia (sleeplessness)
- Nervousness
- Throat tightness
20-29:
- Injection site haematoma (localized swelling filled with blood at injection site)
- Optic neuritis (optic nerve inflammation)
- Vitamin b12 deficiency
- Vitamin d deficiency
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Device related infection
- Intervertebral disc degeneration (spinal disc degeneration)
- Platelet disorder
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
30-39:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Vision blurred
- Muscular weakness (muscle weakness)
- Hypoaesthesia (reduced sense of touch or sensation)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Migraine (headache)
- Anxiety
- Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
40-49:
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Blood pressure increased
- Diplopia (double vision)
- Dizziness
- Injection site discolouration
- Injection site pain
- Injection site swelling
- Lhermitte's sign (an electrical sensation that runs down the back and into the limbs)
- Memory impairment
- Stress
50-59:
- Injection site erythema (redness at injection site)
- Contusion (a type of hematoma of tissue in which capillaries)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Muscular weakness (muscle weakness)
- Nasopharyngitis (inflammation of the nasopharynx)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Dizziness
- Injection site bruising
- Memory impairment
- Asthenia (weakness)
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Extavia and Naproxen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Extavia and Naproxen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Extavia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Naproxen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Extavia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naproxen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on interferon beta-1b and naproxen (the active ingredients of Extavia and Naproxen, respectively), and Extavia and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lamisil and Intal - now
- Drug interactions of Fluticasone Propionate and Arg - 7 seconds ago
- Could Temazepam cause Metabolic Syndrome? - 8 seconds ago
- Could Haloperidol cause Staphylococcal Infection? - 12 seconds ago
- Could Mupirocin cause Atherosclerosis? - 17 seconds ago
- Could Xeloda cause Eosinophil Percentage Increased? - 23 seconds ago
- Heart Palpitations and Ear Discomfort - 24 seconds ago
- Could Bisacodyl cause Myoclonus? - 24 seconds ago
- Could Neulasta cause Dyspnea Exacerbated? - 25 seconds ago
- Could Glipizide cause Sputum Discolored? - 28 seconds ago